ARCHIVES

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

People Spotlight Article

A. Lindo Patterson: Pioneer and Mentor

October 26, 2021

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013